Reliance on Clinical Signs and Symptoms Assessment Leads to Misuse of Antimicrobials: Post hoc Analysis of 350 Chronic Wounds
Thomas E. Serena1, Lisa Gould2, Karen Ousey3, and Robert S. Kirsner4
1SerenaGroup, Pittsburgh, PA
2South Shore Hospital Center for Wound Healing, Weymouth, MA
3Institute of Skin Integrity and Infection Prevention, University of Huddersfield, UK
4University of Miami Hospital and Clinics Wound Center, Miami, FL.
Advances in Wound Care, Vol. 11, #12, 2022
Related Publications

Anti-Microbial Stewardship

Anti-Microbial Stewardship


Anti-Microbial Stewardship

Anti-Microbial Stewardship

Anti-Microbial Stewardship
MolecuLight Headquarters
425 University Avenue Suite 700 Toronto, ON M5G 1T6 Canada
US Address MolecuLight Corp. 2403 Sidney Street, Suite 286 Pittsburgh, PA 15203
T. 1-877-818-4360
North American Toll Free:
1-877-818-4360
F.+1 647-362-4730
E: info@moleculight.com
©2025
The MolecuLight® i:X and MolecuLightDX™ Imaging Devices are approved by Health Canada for sale in Canada and has CE marking for sale in the European Union.
The MolecuLight™ i:X and DX Imaging Devices have received FDA clearance.